Position in NTRA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,786
+$5,987 QoQ
Shares Held
25
+525.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#770
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $612,496 across 21 Diagnostics & Research names. NTRA ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,162 | $411,817 | |
| 2 | WAT |
Waters Corp /De/
|
199 | $74,632 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
122 | $61,165 | |
| 4 | DGX |
Quest Diagnostics Inc
|
218 | $46,205 | |
| 5 | NTRA |
Natera, Inc.
This page
|
25 | $6,786 | |
| 6 | ILMN |
Illumina, Inc.
|
20 | $3,516 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
5 | $2,632 | |
| 8 | LH |
Labcorp Holdings Inc.
|
8 | $2,240 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,786 | 25 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $799 | 4 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,145 | 5 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $482 | 3 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $337 | 2 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||